AUSTIN, Texas (June 14, 2021) —Satellite Healthcare today announced it will participate in an ongoing clinical trial sponsored by DEKA Research & Development Corp. (DEKA). The study is investigating the clinical use of the HemoCare® Hemodialysis System, a new home hemodialysis machine that has been designed by DEKA with a goal to make overnight hemodialysis safer and easier to perform.
“Satellite Healthcare has a long history of bringing home dialysis innovation to patients with kidney disease. We are proud to bring this opportunity to our dialysis patients in the Austin market,” said Dr. Brigitte Schiller, Chief Medical Officer at Satellite Healthcare.
The trial, conducted with study partner CVS Kidney Care, will assess the safety and performance of the HemoCare Hemodialysis System. Eligible patients and their care partners will receive training on the machine in their own homes and transition to overnight home hemodialysis. The study is designed to collect and analyze all adverse safety events and routine lab tests that measure the efficacy of dialysis delivered by the machine.
“Home hemodialysis that is done frequently and for longer durations, especially when performed in the home setting, is associated with improved heart health, patient survival and quality of life. We look forward to the completion of this study, and ultimately FDA clearance, to allow more patients access to this therapy,” said Bruce Culleton, Chief Medical Officer at CVS Kidney Care. “Satellite Healthcare and CVS Kidney Care are committed to providing patients with technology that supports all forms of home dialysis. Studies such as this allow us to do just that and align with the future direction of kidney care in the United States.”
DEKA has a long history of developing successful medical devices including peritoneal dialysis machines, infusion pumps, and solutions for people with disabilities, including the LUKE prosthetic arm and iBot® Personal Mobility Device. CVS Kidney Care and Satellite Healthcare are collaborating nationally to support comprehensive kidney care, and to expand access to kidney transplantation and in-home dialysis.
About Satellite Healthcare
Satellite Healthcare, Inc. is a leading, national not-for-profit kidney care company that has been dedicated to making life better for patients with kidney disease since 1974. Satellite Healthcare and its entities provide in-center and home dialysis services, innovative research and clinical trials as well as early and end-stage kidney disease management. Our focus is to improve the quality and access of dialysis care, reduce costs and implement integrated value-based care models. Satellite Healthcare has more than 80 dialysis centers in five states and relationships with some of the most prestigious nephrologists and institutions in the United States. In addition, Satellite Healthcare has a well-recognized, enduring commitment to philanthropy and community service, from funding millions of dollars in research grants to sponsoring kidney programs nationwide. For more information, visit satellitehealthcare.com.
About DEKA Research and Development Corp.
Based in Manchester, New Hampshire, DEKA is a research and development company of nearly 800 employees comprised of engineering, manufacturing and quality assurance professionals focused on the development of new technologies that span a diverse set of applications. The company was founded in 1982 by Dean Kamen, an inventor who holds hundreds of U.S. and foreign patents and numerous awards, many of them for innovative medical devices that have expanded the frontiers of healthcare worldwide.